JP2018519834A5 - - Google Patents

Download PDF

Info

Publication number
JP2018519834A5
JP2018519834A5 JP2018500473A JP2018500473A JP2018519834A5 JP 2018519834 A5 JP2018519834 A5 JP 2018519834A5 JP 2018500473 A JP2018500473 A JP 2018500473A JP 2018500473 A JP2018500473 A JP 2018500473A JP 2018519834 A5 JP2018519834 A5 JP 2018519834A5
Authority
JP
Japan
Prior art keywords
syndrome
disease
autoimmune
tailpiece
granulomatosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018500473A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018519834A (ja
JP7097293B2 (ja
Filing date
Publication date
Priority claimed from GBGB1511787.2A external-priority patent/GB201511787D0/en
Application filed filed Critical
Publication of JP2018519834A publication Critical patent/JP2018519834A/ja
Publication of JP2018519834A5 publication Critical patent/JP2018519834A5/ja
Application granted granted Critical
Publication of JP7097293B2 publication Critical patent/JP7097293B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018500473A 2015-07-06 2016-07-06 ヒトFc受容体に結合する融合タンパク質 Expired - Fee Related JP7097293B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1511787.2 2015-07-06
GBGB1511787.2A GB201511787D0 (en) 2015-07-06 2015-07-06 Proteins
PCT/EP2016/065914 WO2017005767A1 (en) 2015-07-06 2016-07-06 Fusion proteins which bind to human fc receptors

Publications (3)

Publication Number Publication Date
JP2018519834A JP2018519834A (ja) 2018-07-26
JP2018519834A5 true JP2018519834A5 (cg-RX-API-DMAC10.html) 2021-10-28
JP7097293B2 JP7097293B2 (ja) 2022-07-07

Family

ID=54013529

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018500473A Expired - Fee Related JP7097293B2 (ja) 2015-07-06 2016-07-06 ヒトFc受容体に結合する融合タンパク質

Country Status (10)

Country Link
US (1) US20180194856A1 (cg-RX-API-DMAC10.html)
EP (1) EP3319991A1 (cg-RX-API-DMAC10.html)
JP (1) JP7097293B2 (cg-RX-API-DMAC10.html)
CN (1) CN108473571B (cg-RX-API-DMAC10.html)
AU (1) AU2016290523B2 (cg-RX-API-DMAC10.html)
BR (1) BR112017028331A2 (cg-RX-API-DMAC10.html)
CA (1) CA2991363A1 (cg-RX-API-DMAC10.html)
EA (1) EA201890225A1 (cg-RX-API-DMAC10.html)
GB (1) GB201511787D0 (cg-RX-API-DMAC10.html)
WO (1) WO2017005767A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106068274A (zh) 2014-03-05 2016-11-02 Ucb生物制药私人有限公司 多聚体Fc蛋白
IL309260B2 (en) 2015-07-24 2025-01-01 Gliknik Inc Fusion proteins of human protein fragments to create ordered multimeric immunoglobulin FC preparations with enhanced complement binding
GB201607979D0 (en) * 2016-05-06 2016-06-22 Liverpool School Tropical Medicine Monomeric proteins and uses thereof
CA3026420A1 (en) 2016-06-07 2017-12-14 Gliknik Inc. Cysteine-optimized stradomers
KR20190032392A (ko) 2016-07-22 2019-03-27 글리크닉 인코포레이티드 향상된 fc 수용체 결합을 갖는 규칙적으로 다량체화된 면역글로불린 fc 조성물을 생성하기 위한 인간 단백질 단편의 융합 단백질
BR112019009495A2 (pt) 2016-12-09 2019-08-06 Gliknik Inc métodos de tratamento de distúrbios inflamatórios com compostos de fc multivalentes
JP7351835B2 (ja) * 2017-12-14 2023-09-27 ツェー・エス・エル・ベーリング・レングナウ・アクチエンゲゼルシャフト 視神経脊髄炎の処置のための組換えIgG Fc多量体
AU2019235513B2 (en) * 2018-03-16 2026-01-29 Liverpool School Of Tropical Medicine Chimeric Fc receptor binding proteins and uses thereof
CN115724985A (zh) * 2021-08-27 2023-03-03 三生国健药业(上海)股份有限公司 一种cdc平台抗体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020147326A1 (en) * 1996-06-14 2002-10-10 Smithkline Beecham Corporation Hexameric fusion proteins and uses therefor
US6475749B1 (en) * 1999-08-11 2002-11-05 The Regents Of The University Of California Rh hybrid antibody
DE10001372A1 (de) * 2000-01-14 2001-08-02 Deutsches Krebsforsch Anti-CD3-Einzelketten-Antikörper mit humanem Cmu3- und Cmu4- Domänen
GB0922209D0 (en) * 2009-12-18 2010-02-03 Univ Nottingham Proteins, nucleic acid molecules and compositions
CA2888519C (en) * 2012-10-17 2023-02-21 Liverpool School Of Tropical Medicine Immunomodulatory proteins
CN106068274A (zh) * 2014-03-05 2016-11-02 Ucb生物制药私人有限公司 多聚体Fc蛋白
CN106132994A (zh) * 2014-03-05 2016-11-16 Ucb生物制药私人有限公司 多聚体Fc蛋白
CA2978501A1 (en) * 2015-03-05 2016-09-09 Ucb Biopharma Sprl Polymeric fc proteins and methods of screening to alter their functional characteristics

Similar Documents

Publication Publication Date Title
JP2018527011A5 (cg-RX-API-DMAC10.html)
Dinarello et al. Treating inflammation by blocking interleukin-1 in humans
ZA202201378B (en) Anti-cd154 antibodies and uses thereof
FI3985002T3 (fi) Aryyli-, heteroaryyli- ja heterosyklisiä lääkeyhdisteitä sairauksien hoitoon
PH12016500791B1 (en) Novel amino pyrimidine derivatives
MX2014000338A (es) Derivados de pirrolo-pirimidina novedoso.
HRP20191199T1 (hr) Formulacije protutijela anti-prolaktinskog receptora
JP2024531259A5 (cg-RX-API-DMAC10.html)
JP2017520571A5 (cg-RX-API-DMAC10.html)
JP2016503010A5 (cg-RX-API-DMAC10.html)
JP2024504366A5 (cg-RX-API-DMAC10.html)
JP2013535445A5 (cg-RX-API-DMAC10.html)
JP2019509986A5 (cg-RX-API-DMAC10.html)
JP2025515191A5 (cg-RX-API-DMAC10.html)
Tanabe et al. B lymphocytes: crucial contributors to brain development and neurological diseases
JP2024542096A5 (cg-RX-API-DMAC10.html)
US20260083671A1 (en) Stabilized formulation comprising recombinant stabilized galectin 9 protein
JP2015519355A5 (cg-RX-API-DMAC10.html)
IL277103B1 (en) IgG-stimulated remyelination of peripheral nerves
JP2024541995A5 (cg-RX-API-DMAC10.html)
JP2024541994A5 (cg-RX-API-DMAC10.html)
JP2024541975A5 (cg-RX-API-DMAC10.html)
JP2024546654A5 (cg-RX-API-DMAC10.html)
JP2025516364A5 (cg-RX-API-DMAC10.html)
NZ747665B2 (en) Cd200 mutant and its uses